Vnitr Lek 2012, 58(1):24-30

Endocrine changes in liver disease

J. Kollerová*, T. Koller, J. Payer
V. interná klinika Lekárskej fakulty UK a UNB Bratislava, Slovenská republika, prednosta prof. MUDr. Juraj Payer, CSc.

Liver diseases have an influence on function and morphology of all endocrine glands. Knowledge of these specific changes is important in correct interpretation of pathological clinical and laboratory hormonal symptoms and signs induced by liver disease. We analyze the influence on the thyroid, bone metabolism, adrenocorticotropic axis, gonadal hormones, prolactin and growth hormone.

Keywords: liver; liver disease; thyroid disease; bone changes; cortisol; gonadal hormones; prolactin; growth hormone

Received: March 16, 2011; Accepted: April 17, 2011; Published: January 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kollerová J, Koller T, Payer J. Endocrine changes in liver disease. Vnitr Lek. 2012;58(1):24-30.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Liewendahl K, Helenius T, Tanner P et al. Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis. Acta Endocrinol Suppl (Copenh) 1983; 251: 21-26. Go to PubMed...
    2. Antonelli A, Ferri C, Ferrari SM et al. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 2009; 5: 26-34. Go to original source... Go to PubMed...
    3. Pateron D, Hartmann DJ, Duclos-Vallée JC et al. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1993; 17: 417-419. Go to original source... Go to PubMed...
    4. Antonelli A, Ferri C, Fallahi P et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563-572. Go to original source... Go to PubMed...
    5. Antonelli A, Ferri C, Pampana A et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-13. Go to original source... Go to PubMed...
    6. Matskevich AA, Strayer DS. Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma. Gene Ther 2003; 10: 1861-1873. Go to original source... Go to PubMed...
    7. Murata M, Nabeshima S, Maeda N et al. Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 2002; 67: 162-170. Go to original source... Go to PubMed...
    8. Antonelli A, Ferri C, Fallahi P et al. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447-451. Go to original source... Go to PubMed...
    9. Giordano TP, Henderson L, Landgren O et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-2017. Go to original source... Go to PubMed...
    10. Güven K, Kelestimur F, Yücesoy M. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy. Eur J Med 1993; 2: 83-85.
    11. Gelu-Simeon M, Burlaud A, Young J et al. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009; 15: 328-333. Go to original source... Go to PubMed...
    12. Kirch W, Höfig M, Ledendecker T et al. Parathyroid hormone and cirrhosis of the liver. J Clin Endocrinol Metab 1990; 71: 1561-1566. Go to original source... Go to PubMed...
    13. Groote Veldman R, Meinders AE. On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr Rev 1996; 17: 262-268. Go to original source...
    14. Marik PE, Gayowski T, Starzl TE. Hepatic Cortisol Research and Adrenal Pathophysiology Study Group. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005; 33: 1254-1259. Go to original source... Go to PubMed...
    15. Triantos C, Marzigie M, Fede G et al. Adrenal insufficiency in patients with cirrhosis and variceal bleeding. J Hepatol 2010; 52 (Suppl 1): S174. Go to original source...
    16. Tan T, Chang L, Woodward A et al. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J Hepatol 2010; 53: 841-853. Go to original source... Go to PubMed...
    17. Becker U, Gluud C, Farholt S et al. Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease. J Hepatol 1991; 13: 25-32. Go to original source... Go to PubMed...
    18. Cundy TF, O'Grady JG, Williams R. Recovery of menstruation and pregnancy after liver transplantation. Gut 1990; 31: 337-338. Go to original source... Go to PubMed...
    19. Koller T, Kollerová J, Huorka M et al. Vplyv bazálnej koncentrácie prolaktínu na výskyt komplikácií a na prognózu pacientov s cirhózou pečene. Vnitř Lék 2009; 55: 468-473. Go to PubMed...
    20. Koller T, Payer J. Endokrinné prejavy chorôb pečene. Čes a Slov Gastroent a Hepatol 2007; 61: 150-154.
    21. Zietz B, Lock G, Plach B et al. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 2003; 5: 495-501. Go to original source...
    22. Cuneo RC, Hickman PE, Wallace JD et al. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocrinol (Oxf) 1995; 43: 265-275. Go to original source... Go to PubMed...
    23. Ketelslegers JM, Maiter D, Maes M et al. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins. Horm Res 1996; 45: 252-257. Go to original source... Go to PubMed...
    24. Picardi A, Gentilucci UV, Zardi EM et al. TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res 2003; 23: 229-235. Go to original source... Go to PubMed...
    25. Møller S, Becker U, Juul A et al. Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD group. Hepatology 1996; 23: 1073-1078. Go to original source... Go to PubMed...
    26. Kruszynska Y T, Bouloux BM. The effect of liver disease on the endocrine system. In: Rodés J, Benhamou JP, Blei A (eds). Textbook of Hepatology. Oxford: Blackwell Publishing 2008: 1732-1766. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.